MIRA Pharmaceuticals, Inc. (MIRA) Stock

MIRA Pharmaceuticals, Inc. (MIRA) is a Healthcare stock trading at $0.80 (as of 2026-07-31), with a market capitalization of $33.62M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

MIRA Pharmaceuticals, Inc. is a clinical development-stage biopharmaceutical company focused on developing a synthetic THC analog. Its program includes MIRA1a, a cannabinoid receptor-targeting compound intended for treatment of adult patients with anxiety and cognitive decline associated with early-stage dementia, as well as chronic pain.

Valuation — source: SEC EDGAR (first-party)
Price$0.80
Market Cap$33.62M
Price / Book4.12
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.7
Industry P/E (Pharmaceutical Products)17.0
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($997350.00)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOErez Aminov
Employees2
CountryUS
IPO Date2023-08-14

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Apollomics, Inc. (APLM)
  • Actinium Pharmaceuticals, Inc. (ATNM)
  • Lite Strategy, Inc. (LITS)
  • Actuate Therapeutics Inc (ACTU)
  • IGC Pharma, Inc. (IGC)
  • Lantern Pharma Inc. (LTRN)
  • Daré Bioscience, Inc. (DARE)
  • BeyondSpring Inc. (BYSI)
MIRA earnings history · MIRA institutional & insider holders · MIRA KPIs & operating metrics · MIRA financials · MIRA investor presentations & press releases · MIRA SEC filings · MIRA peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-07-31.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.